59
Participants
Start Date
September 10, 2020
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
ONO-4538
IV infusion over 30 minutes
oxaliplatin
IV infusion over 2 hours
S-1
Administered orally twice daily
capecitabine
Administered orally twice daily
bevacizumab
IV infusion over 30 minutes
temozolomide
Administered orally once daily for 5 days every 28 days
RECRUITING
Chiba Clinical Site1, Kashiwa
COMPLETED
Ehime Clinical Site1, Matsuyama
RECRUITING
Fukuoka Clinical Site1, Kurume
RECRUITING
Hokkaido Clinical Site1, Sapporo
RECRUITING
Hyogo Clinical Site1, Akashi
RECRUITING
Kanagawa Clinical Site1, Yokohama
RECRUITING
Oita Clinical Site1, Yufu
RECRUITING
Osaka Clinical Site1, Suita
RECRUITING
Osaka Clinical Site3, Takatsuki
RECRUITING
Saitama Clinical Site1, Hidaka
RECRUITING
Saitama Clinical Site2, Kitaadachi-gun
RECRUITING
Tokyo Clinical Site3, Bunkyo-ku
RECRUITING
Tokyo Clinical Site2, Chuo-ku
RECRUITING
Tokyo Clinical Site1, Koto-ku
RECRUITING
Tokyo Clinical Site4, Shinjuku-ku
RECRUITING
Chiba Clinical Site2, Chiba
RECRUITING
Fukuoka Clinical Site2, Fukuoka
RECRUITING
Fukuoka Clinical Site3, Fukuoka
RECRUITING
Hiroshima Clinical Site1, Hiroshima
RECRUITING
Kyoto Clinical Site1, Kyoto
RECRUITING
Okayama Clinical Site1, Okayama
RECRUITING
Osaka Clinical Site2, Osaka
RECRUITING
Daegu Clinical Site1, Daegu
RECRUITING
Gyeonggi-do Clinical site1, Gyeonggi-do
RECRUITING
Incheon Clinical Site1, Incheon
RECRUITING
Seoul Clinical Site1, Seoul
COMPLETED
Seoul Clinical Site2, Seoul
RECRUITING
Seoul Clinical Site3, Seoul
RECRUITING
Seoul Clinical Site4, Seoul
RECRUITING
Seoul Clinical Site5, Seoul
RECRUITING
Seoul Clinical Site6, Seoul
COMPLETED
Kaohsiung Clinical Site1, Kaohsiung City
COMPLETED
Kaohsiung Clinical Site2, Kaohsiung City
RECRUITING
Tainan Clinical Site1, Tainan City
RECRUITING
Tainan Clinical Site2, Tainan City
RECRUITING
Taipei Clinical Site1, Taipei
RECRUITING
Taipei Clinical Site2, Taipei
RECRUITING
Taoyuan Clinical Site1, Taoyuan District
Lead Sponsor
Ono Pharmaceutical Co. Ltd
INDUSTRY